Examination Report |
1 | TM-1 | 17 Sep 2013 |
2 | Reply to Exam Report (MIS-R) | 25 Jul 2016 |
3 | Journal Copy | 06 Feb 2017 |
4 | TM-O(NOTICE OF OPPOSITION) | 11 May 2017 |
5 | TM-O(NOTICE OF OPPOSITION) | 17 May 2017 |
6 | TM-O(NOTICE OF OPPOSITION) | 25 May 2017 |
7 | Letter of Withdrawal | 20 Dec 2017 |
8 | Letters related to TOP | 10 Jan 2018 |
1 | Dispatching of Examination Report for : 2597130 | 2700316 | 1332219 | 08 Jan 2016 |
2 | Abandoned Order for Application No 2597130 | 3260280 | 1641153 | 30 Mar 2016 |
3 | Opposition Notice | 5182235 | 04 Oct 2017 | |
4 | Opposition Notice | 5191876 | 05 Oct 2017 | |
5 | Opposition Notice | 5198450 | 06 Oct 2017 |
The application for Betadiz was made on 17 September 2013.
The trademark applicant for Betadiz is CENTAUR PHARMACEUTICALS.
Betadiz is applied in class(es) 5.
Application for Betadiz is on Opposed stage.
Application Id allotted to Betadiz is 2597130.
Trademark agent or attorney for the application is B.N. Poojari.
Betadiz filed with the Intellectual property office as a WORD.